Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
1985
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
C09AA02
|
| gptkbp:brand |
gptkb:enalapril
|
| gptkbp:chemicalFormula |
C20H28N2O5
|
| gptkbp:contraindication |
pregnancy
bilateral renal artery stenosis history of angioedema |
| gptkbp:drugClass |
ACE inhibitor
|
| gptkbp:eliminationHalfLife |
11 hours
|
| gptkbp:excretion |
gptkb:kidney
|
| https://www.w3.org/2000/01/rdf-schema#label |
Vasotec
|
| gptkbp:legalStatus |
Rx-only
|
| gptkbp:manufacturer |
gptkb:Merck_&_Co.
|
| gptkbp:metabolism |
liver
|
| gptkbp:pregnancyCategory |
D (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
dizziness
cough hyperkalemia angioedema |
| gptkbp:usedFor |
congestive heart failure
hypertension left ventricular dysfunction |
| gptkbp:bfsParent |
gptkb:Merck_&_Co.
|
| gptkbp:bfsLayer |
4
|